Title |
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension |
|---|---|
Involved |
for the FREEDOM-EV Investigators (Verfasser)
Ekkehard Grünig (Verfasser) Franck Rahaghi (Verfasser) Jean Elwing (Verfasser)
Carmine Dario Vizza (Verfasser)
Joanna Pepke-Zaba (Verfasser) Jieyan Shen (Verfasser) Hua Yao (Verfasser) Antoine Hage (Verfasser) Stephan Rosenkranz (Verfasser) Madelon Vonk (Verfasser) Vijay Balasubramanian (Verfasser) Yang Yuanhua (Verfasser) Zaixin Yu (Verfasser) James Lordan (Verfasser) Linda Cadaret (Verfasser) Rob Grover (Verfasser) Aliou Ousmanou (Verfasser) Scott Seaman (Verfasser) Chunqin Deng (Verfasser) Meredith Broderick (Verfasser) R. James White (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Advances in therapy 41, 2, 6.12.2023, date:2.2024, Seite 618-637 |
Published |
2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Internal Medicine.
Oncology. Cardiology. Rheumatology.
Endocrinology.
Pharmacology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024041316141773827778 (URN) |
Record ID |
1326082116 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: